Clinitech Laboratory’s IPO is a fixed price issue of Rs 5.78 crores, consisting entirely of a fresh issue of 6.02 lakh shares.
The IPO bidding opened for subscription on July 25, 2024, and will close on July 29, 2024. The allotment is expected to be finalized on Tuesday, July 30, 2024, with a tentative listing date on BSE SME set for Thursday, August 1, 2024.
The IPO price is ₹96 per share, with a minimum application lot size of 1200 shares, requiring an investment of ₹115,200 for retail investors. For HNIs, the minimum lot size is 2 lots (2,400 shares), amounting to ₹230,400.
- Book Running Lead Manager of Clinitech IPO – Inventure Merchant Banker Services Pvt Ltd.
- Registrar for the issue – Bigshare Services Pvt Ltd.
- Market Maker for Clinitech Laboratory IPO – Svcm Securities.
Below are the details of Clinitech Laboratory Limited IPO 2024 Details, Timeline, Lot Size, Anchor Investor, and Promoter Holding.
Track All IPOs opening and closing today on our comprehensive list of IPO Watchlist 2024!
Clinitech Laboratory Limited IPO 2024 Details
IPO Date | July 25, 2024 to July 29, 2024 |
Listing Date | [.] |
Face Value | ₹10 per share |
Price | ₹96 per share |
Lot Size | 1200 Shares |
Total Issue Size | 602,400 shares (aggregating up to ₹5.78 Cr) |
Fresh Issue | 602,400 shares (aggregating up to ₹5.78 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | BSE SME |
Share holding pre issue | 1,680,000 |
Share holding post issue | 2,282,400 |
Market Maker portion | 31,200 shares Svcm Securities |
Clinitech Laboratory IPO 2024 Timeline
Event | Timeline |
---|---|
IPO Open Date | Thursday, July 25, 2024 |
IPO Close Date | Monday, July 29, 2024 |
Basis of Allotment | Tuesday, July 30, 2024 |
Initiation of Refunds | Wednesday, July 31, 2024 |
Credit of Shares to Demat | Wednesday, July 31, 2024 |
Listing Date | Thursday, August 1, 2024 |
Cut-off time for UPI mandate confirmation | 5 PM on July 29, 2024 |
Clinitech Laboratory IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 1200 | ₹115,200 |
Retail (Max) | 1 | 1200 | ₹115,200 |
HNI (Min) | 2 | 2,400 | ₹230,400 |
Clinitech Laboratory Limited IPO Reservation
Investor Category | Shares Offered |
---|---|
Anchor Investor Shares Offered | – |
Market Maker Shares Offered | 31,200 (5.18%) |
Other Shares Offered | 301,200 (50.00%) |
Retail Shares Offered | 301,200 (50.00%) |
Total Shares Offered | 602,400 (100%) |
Clinitech Laboratory Limited IPO Promoters
Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak are the promoters of the company.
Share Holding Pre Issue | 83.63% |
Share Holding Post-Issue | 61.56% |
Clinitech IPO 2024 Restated Financial Information
Clinitech Laboratory Ltd’s revenue increased by 1.19% and its profit after tax dropped by -39.46% b/w March 31, 2024 and March 31, 2024.
Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
Assets | 560.79 | 603.33 | 368.74 | 273.32 |
Revenue | 643.92 | 636.34 | 645.70 | 459.63 |
Profit After Tax | 37.12 | 61.31 | 51.26 | 40.24 |
Net Worth | 354.80 | 238.08 | 184.81 | 139.03 |
Reserves and Surplus | 186.80 | 88.08 | 34.81 | 72.37 |
Total Borrowing | 86.31 | 102.91 | 88.61 | 53.67 |
Clinitech Laboratory Ltd. (CLL) operates diagnostic centers in Thane and Navi Mumbai, conducting over 3 lakh tests annually with a range of services. The company’s revenue is mainly from B2C, with B2B contributing 20.33% for FY24. It has 85 employees as of May 31, 2024.
CLL’s IPO offers 602,400 shares at Rs. 96 each to raise Rs. 5.78 crores, opening July 25 and closing July 29, 2024. Proceeds will fund diagnostic center expansion and general purposes. Post-IPO, the capital will rise to Rs. 2.28 crores, targeting a market cap of Rs. 21.91 crores. Financials show static revenue with fluctuating profits, and the issue is priced at a P/E of 58.90, considered high. The company has not declared dividends.
Visit Clinitech Laboratory Ltd. Official Website: Click here!